Waldenström macroglobulinaemia (supportive care)
Also known as: Waldenstrom macroglobulinemia, Waldenström disease, IgM-associated lymphoplasmacytic lymphoma, LPL/WM
Waldenström macroglobulinaemia is a lymphoplasmacytic lymphoma defined by monoclonal IgM production. Clinical manifestations result from marrow infiltration, monoclonal protein sequelae, or treatment-related toxicities. Primary clinical responsibility resides with the haematology multidisciplinary team. In an adjunctive capacity, Traditional Chinese Medicine (TCM) may address fatigue, anorexia, and insomnia, provided such interventions do not impede standard oncological protocols. Current citations do not establish the clinical efficacy of acupuncture or Chinese herbal medicine for this malignancy, focusing instead on diagnostic pitfalls, hepatotoxicity risk, and survivorship. TCM patterns represent traditional constructs rather than pathological subtypes. All TCM interventions necessitate rigorous individual assessment, monitoring of haematological indices and pharmacology, and coordination with treating specialists.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere strictly to all haematology consultations, prescribed therapeutic regimens, and vaccination schedules; maintain compliance with the agreed survivorship screening protocol.
- •Prioritise nutrient-dense, easily tolerated meals and engage dietetic support for persistent anorexia; strictly observe any medically prescribed fluid restrictions.
- •Implement a balance between rest and gentle activity, adapting to fatigue, peripheral neuropathy, dizziness, and falls risk.
- •Maintain a comprehensive record of symptoms and medications, covering fatigue levels, sleep, appetite, temperature when unwell, and all supplements.
Cautions & Contraindications
- •Avoid starting or continuing a suspected hepatotoxic herbal product when liver injury is being investigated; obtain prompt prescriber review. The supplied DILI review does not establish safety or effectiveness of these formulas, and laboratory-marker improvement is not proof of patient benefit.[]
- •Defer elective acupuncture during suspected systemic infection and obtain oncology clearance when immunosuppression is substantial. This is a precaution informed by the infection context in the supplied case, not a needling protocol evaluated by that report.[]
- •Do not use a TCM diagnosis to explain an isolated creatinine abnormality or recommend kidney-directed herbs without medical assessment. The supplied title raises possible assay interference but provides no abstract-supported diagnostic method.[]
- •Do not let symptom relief replace long-term haematological surveillance or investigation of unexplained new cytopenias. The supplied cohort highlights selective survivorship concerns, including myeloid malignancies, without demonstrating broadly increased overall cancer risk.[]
When to reassess or seek care again
Record baseline fatigue and sleep disturbance on 0–10 scales, appetite, weight trend and daily function. Review after 2–4 weeks, or sooner if symptoms worsen, with relevant blood counts and organ-function results interpreted by the treating team. Stop or revise adjunctive care if there is no meaningful symptom improvement, adverse effects occur or treatment burden outweighs benefit. New neurological or visual symptoms, bleeding, fever, unexplained weight loss or deteriorating counts require medical escalation rather than further pattern treatment. Symptom improvement must not be interpreted as lymphoma response.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Nephrology (Carlton, Vic.) · 2023
- Frontiers in pharmacology · 2021
- British journal of haematology · 2026
- European journal of case reports in internal medicine · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
